Form 8-K - Current report:
SEC Accession No. 0001213900-25-077719
Filing Date
2025-08-18
Accepted
2025-08-18 08:01:32
Documents
15
Period of Report
2025-08-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0253416-8k_ethzilla.htm   iXBRL 8-K 31661
2 PRESS RELEASE, DATED AUGUST 18, 2025 ea025341601ex99-1_ethzilla.htm EX-99.1 25577
7 GRAPHIC ex99-1_001.jpg GRAPHIC 10698
  Complete submission text file 0001213900-25-077719.txt   293010

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE atnf-20250818.xsd EX-101.SCH 3786
4 XBRL DEFINITION FILE atnf-20250818_def.xml EX-101.DEF 27070
5 XBRL LABEL FILE atnf-20250818_lab.xml EX-101.LAB 37355
6 XBRL PRESENTATION FILE atnf-20250818_pre.xml EX-101.PRE 25691
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0253416-8k_ethzilla_htm.xml XML 5859
Mailing Address 2875 SOUTH OCEAN SUITE 200 PALM BEACH FL 33480
Business Address 2875 SOUTH OCEAN SUITE 200 PALM BEACH FL 33480 650-507-0669
ETHZilla Corp (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 251226315
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)